Skip to content

Research at St Andrews

Impact of human cytomegalovirus on glioblastoma cell viability and chemotherapy treatment

Research output: Contribution to journalArticle

DOI

Open Access permissions

Open

Author(s)

Claudia Januário dos Santos, Fabiane Lucy Ferreira Castro, Rodrigo Barbosa de Aguiar, Isabela Godoy Menezes, Ana Carolina Santos, Christina Paulus, Michael Nevels, Maria Cristina Carlan da Silva

School/Research organisations

Abstract

The relationship between human cytomegalovirus (HCMV) and tumours has been extensively investigated, mainly in glioblastoma multiforme (GBM), a malignant tumour of the central nervous system with low overall survival rates. Several reports have demonstrated the presence of HCMV in GBM, although typically restricted to a low number of cells, and studies have indicated that viral proteins have the ability to dysregulate cellular processes and increase tumour malignancy. Treatment of GBM involves the use of the chemotherapeutic agents temozolomide (TMZ) and carmustine (bis-chloroethylnitrosourea, BCNU), which lead to the attachment of adducts to the DNA backbone, causing errors during replication and consequent cell death. It is known that HCMV infection can modulate DNA repair pathways, but what effects the virus may exhibit during chemotherapy are unknown. Here we approach this question by analysing HCMV infection and viral protein accumulation in GBM cell lines with different genotypes and their response to TMZ and BCNU in the presence of the virus. We demonstrate that A172, TP365MG and U251MG GBM cells are efficiently infected by both low-passage (TB40E) and high-passage (AD169) HCMV strains. However, the GBM cell lines vary widely in their permissiveness to viral gene expression and exhibit very different patterns of immediate early, early and late protein accumulation. HCMV reduces the viability of permissive GBM cells in a multiplicity-dependent manner in both the absence and presence of TMZ or BNCU. In sum, we demonstrate that GBM cell lines are equally susceptible but differentially permissive to infection by both low- and high-passage strains of HCMV. This observation not only indicates that viral replication is largely controlled by cellular factors in this system, but also provides a possible explanation for why viral gene products are only found in a subset of cells in GBM tumours. Furthermore, we conclude that the virus does not confer increased resistance to chemotherapeutic drugs in various GBM cell lines, but instead reduces tumour cell viability. These results highlight that the oncomodulatory potential of HCMV is not limited to cancer-promoting activities, but also includes adverse effects on tumour cell proliferation or survival.
Close

Details

Original languageEnglish
Pages (from-to)1274-1285
Number of pages12
JournalJournal of General Virology
Volume99
Issue number9
Early online date27 Jul 2018
DOIs
Publication statusPublished - Sep 2018

    Research areas

  • Human Cytomegalovirus (CMV), Glioblastoma multiforme, Chemotherapy, Temozolomide, Carmustine

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Non-canonical activation of the DNA sensing adaptor STING by ATM and IFI16 mediates NF-κB signalling after nuclear DNA damage

    Dunphy, G., Flannery, S. M., Almine, J. F., Connolly, D. J., Paulus, C., Jonsson, K. L., Jakobsen, M. R., Nevels, M. M., Bowie, A. G. & Unterholzner, L., 6 Sep 2018, In : Molecular Cell. 71, 5, p. 745-760 22 p., e5.

    Research output: Contribution to journalArticle

  2. Human cytomegalovirus immediate early 1 protein causes loss of SOX2 from neural progenitor cells by trapping unphosphorylated STAT3 in the nucleus

    Wu, C-C., Jiang, X., Wang, X-Z., Liu, X-J., Li, X-J., Yang, B., Ye, H-Q., Harwardt, T., Jiang, M., Xia, H-M., Wang, W., Britt, W. J., Paulus, C., Nevels, M. M. & Luo, M-H., Sep 2018, In : Journal of Virology. 92, 17, e00340-18.

    Research output: Contribution to journalArticle

  3. Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice

    Vasou, A., Paulus, C., Narloch, J., Gage, Z. O., Rameix-Welti, M-A., Eléouët, J-F., Nevels, M., Randall, R. E. & Adamson, C. S., Feb 2018, In : Antiviral Research. 150, p. 79-92

    Research output: Contribution to journalArticle

  4. ARID3B: a novel regulator of the Kaposi’s sarcoma-associated herpesvirus lytic cycle

    Wood, J., Boyne, J., Paulus, C., Jackson, B., Nevels, M. M., Whitehouse, A. & Hughes, D. J., Oct 2016, In : Journal of Virology. 90, 20, p. 9543-9555

    Research output: Contribution to journalArticle

  5. Human cytomegalovirus immediate-early 1 protein rewires upstream STAT3 to downstream STAT1 signaling switching an IL6-type to an IFNγ-like response

    Harwardt, T., Lukas, S., Zenger, M., Reitberger, T., Danzer, D., Übner, T., Munday, D. C., Nevels, M. & Paulus, C., 7 Jul 2016, In : PLoS Pathogens. 12, 7, 39 p., e1005748.

    Research output: Contribution to journalArticle

Related by journal

  1. Journal of General Virology (Journal)

    Rupert James Martin Russell (Member of editorial board)
    2008 → …

    Activity: Publication peer-review and editorial work typesEditor of research journal

  2. Journal of General Virology (Journal)

    Richard Michael Elliott (Editor)
    20082012

    Activity: Publication peer-review and editorial work typesEditor of research journal

  3. Journal of General Virology (Journal)

    Richard Michael Elliott (Member of editorial board)
    20022006

    Activity: Publication peer-review and editorial work typesEditor of research journal

  4. Journal of General Virology (Journal)

    Richard Michael Elliott (Editor)
    19962001

    Activity: Publication peer-review and editorial work typesEditor of research journal

  5. Journal of General Virology (Journal)

    Richard Michael Elliott (Member of editorial board)
    19871991

    Activity: Publication peer-review and editorial work typesEditor of research journal

Related by journal

  1. Kodoja: a workflow for virus detection in plants using k-mer analysis of RNA-sequencing data

    Baizan-Edge, A., Cock, P., MacFarlane, S., McGavin, W., Torrance, L. & Jones, S., 1 Mar 2019, In : Journal of General Virology. 100, p. 533-542

    Research output: Contribution to journalArticle

  2. The broad-spectrum antiviral drug arbidol inhibits foot-and-mouth disease virus genome replication

    Herod, M. R., Adeyemi, O. O., Ward, J., Bentley, K., Harris, M., Stonehouse, N. J. & Polyak, S. J., 4 Jun 2019, In : Journal of General Virology. 10 p.

    Research output: Contribution to journalArticle

  3. Mechanisms and consequences of positive-strand RNA virus recombination

    Bentley, K. & Evans, D. J., 1 Oct 2018, In : Journal of General Virology. 99, 10, p. 1345-1356

    Research output: Contribution to journalReview article

  4. Human interactome of the influenza B virus NS1 protein

    Patzina, C., Botting, C. H., García-Sastre, A., Randall, R. E. & Hale, B. G., 1 Sep 2017, In : Journal of General Virology. 98, 9, p. 2267-2273 7 p., 000909.

    Research output: Contribution to journalArticle

ID: 253425783